Word: stomachic
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...truly an intellectual wasteland. Required participation forces everyone to say something (whether constructive or not), and the talk usually devolves into a banal rehashing of the past week’s lectures. A typical section is like a cow chewing cud: ideas are digested a bit in one stomach, regurgitated briefly to be considered again, and finally swallowed. And the hated “response paper,” which asks students to reflect on the week’s reading in one short page, makes no pretense of requiring any in-depth knowledge or thought...
...drop. Then he would force his mates to down an entire glass of liquor. When Uday was in the hospital after being shot, he called his friends in to cheer him up. Since he couldn't drink, he forced them to consume obscene quantities of alcohol, installing a stomach-pumping station in the next room for emergencies, says a friend. At the Boat Club, Uday kept a monkey named Louisa in a cage in the kitchen. Louisa had a taste for whiskey and was an angry drunk. If one of Uday's friends passed out in the course...
...barely keeping my stomach above the floor,” Watkins says...
...First of all, just because some students of questionable character are already present among us, why should we lose the right to express moral indignation at an act that, Podolsky admits, “turns [his] stomach?” Is it truly “hypocrisy” to acknowledge that Harvard has some undesirably selfish people, yet simultaneously desire to avoid perpetuating or worsening this state of affairs...
...drug from Swiss pharmaceutical giant Novartis, his pain can be eased with fewer side effects. The FDA has approved Deramaxx, the first animal drug to target the COX-2 enzyme, responsible for arthritic pain, while sparing the COX-1 enzyme, which helps dogs (and people) protect their stomach linings. This relief method puts Deramaxx in the same class as Celebrex (Pfizer) and Vioxx (Merck), which are for humans. Vets expect Deramaxx to cut into sales of Pfizer's Rimadyl and Wyeth's EtoGesic, which dominate the $150 million U.S. dog-arthritis market. Deramaxx will cost about $30 a month. Novartis...